LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-11-01
Case ID: NM_000038.6_c.4348C_T_20261101_171532
Framework: ACMG/AMP 2015
Variant classification summary

NM_000038.6:c.4348C>T

APC  · NP_000029.2:p.(Arg1450Ter)  · NM_000038.6
GRCh37: chr5:112175639 C>T  ·  GRCh38: chr5:112839942 C>T
Gene: APC Transcript: NM_000038.6
Final call
Likely Pathogenic
PVS1 very strong PS4 supporting
All criteria require review: For research and educational purposes only.
Gene
APC
Transcript
NM_000038.6
Protein
NP_000029.2:p.(Arg1450Ter)
gnomAD AF
0.0 (v2.1)
ClinVar
Pathogenic
OncoKB
Likely Oncogenic
Interpretation summary
Generated evidence synthesis
1
Pathogenic evidence: the APC VCEP assigns PVS1 very strong to this codon-1450 nonsense variant.
2
Pathogenic evidence: two unrelated FAP probands provide 1.5 phenotype points, meeting the APC VCEP PS4 supporting threshold.
Final determination: APC VCEP Rule20 classifies a variant as Likely Pathogenic when one PVS1 very strong criterion and one qualifying supporting pathogenic criterion are satisfied; here these are PVS1 and PS4.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 Met Met, very strong: nonsense codon 1450 lies within the APC VCEP's codon 49–2645 interval assigned full PVS1.
vcep_apc_specifications_supplementary_material_v2 vcep_fig_1_apc_pvs1_decision_tree_2023_10_20 pvs1_variant_assessment cspec PMID:26446593 PMID:21110124
PS1 N/A Not applicable: the APC VCEP limits PS1 to missense or splice variants, whereas c.4348C>T produces the nonsense change p.Arg1450Ter.
vcep_apc_specifications_supplementary_material_v2 PMID:26446593 PMID:21110124
PS2 Not assessed Not assessed: two affected probands are reported, but no parental testing or de novo determination is available to assign the VCEP's 1- or 2-point score.
vcep_apc_specifications_supplementary_material_v2 vcep_table_1_262 PMID:26446593 PMID:21110124
PS3 Not assessed Not assessed: no exact-variant RNA or qualifying protein assay result is available to meet the APC VCEP PS3 functional-study requirements.
cspec vcep_apc_specifications_supplementary_material_v2
PS4 Met Met at Supporting: two unrelated FAP probands contribute 1.5 APC phenotype points, matching the VCEP 1–1.5-point Supporting threshold.
cspec vcep_apc_specifications_supplementary_material_v2 vcep_table_1_262 PMID:26446593 PMID:21110124
PM1 N/A Not applicable: the APC VCEP marks PM1 Not Applicable and identifies no approved APC pathogenic missense hotspot or critical-domain route for residue 1450.
vcep_apc_specifications_supplementary_material_v2
PM2 Not assessed Not assessed: VCEP-required non-cancer gnomAD allele count and frequency are unknown because the query failed.
vcep_apc_specifications_supplementary_material_v2 gnomad_v2
PM3 N/A Not applicable: the APC VCEP marks PM3 not applicable for familial adenomatous polyposis.
cspec vcep_apc_specifications_supplementary_material_v2
PM4 N/A Not applicable: APC VCEP PM4 is not used, and this variant is nonsense rather than an in-frame or stop-loss change.
vcep_apc_specifications_supplementary_material_v2
PM5 N/A Not applicable: PM5 is restricted by the APC VCEP to missense variants at positions 1026 or 1028, while this variant is nonsense at Arg1450.
vcep_apc_specifications_supplementary_material_v2
PM6 Not assessed Not assessed: affected probands are reported, but neither source documents assumed de novo status or the parental information required for the VCEP PM6 score.
vcep_apc_specifications_supplementary_material_v2 vcep_table_1_262 PMID:26446593 PMID:21110124
PP1 Not assessed Not assessed: no affected relatives with matching genotypes or segregation data are reported, so the VCEP's minimum 3-meiosis threshold cannot be evaluated.
vcep_apc_specifications_supplementary_material_v2 vcep_table_1_262 PMID:26446593 PMID:21110124
PP2 N/A Not applicable: the APC VCEP explicitly marks PP2 Not Applicable, and the case variant is a nonsense rather than missense variant.
vcep_apc_specifications_supplementary_material_v2
PP3 N/A Not applicable: c.4348C>T is a nonsense variant, while the APC PP3 rule names presumed-missense splicing effects and non-canonical splicing variants.
cspec vcep_apc_specifications_supplementary_material_v2
PP4 N/A Not applicable: the APC VCEP states PP4 is already captured by PS4 and cannot be used as independent evidence.
vcep_apc_specifications_supplementary_material_v2
PP5 N/A Not applicable: the APC VCEP does not use PP5 without the primary evidence underlying an expert opinion.
vcep_apc_specifications_supplementary_material_v2
BA1 Not assessed Not assessed: the VCEP-required non-cancer gnomAD v2.1 Popmax frequency is unknown because that query failed.
vcep_apc_specifications_supplementary_material_v2 gnomad_v2
BS1 Not assessed Not assessed: the VCEP-required non-cancer gnomAD v2.1 Popmax frequency is unknown, so the 0.001% BS1 threshold cannot be evaluated.
vcep_apc_specifications_supplementary_material_v2 gnomad_v2
BS2 Not assessed Not assessed: VCEP-relevant non-cancer gnomAD homozygote data are unavailable because the query failed.
vcep_apc_specifications_supplementary_material_v2 gnomad_v2
BS3 Not assessed Not assessed: no exact-variant assay demonstrates preserved APC function, comparable beta-catenin activity, or absence of mRNA aberration under the VCEP BS3 requirements.
cspec vcep_apc_specifications_supplementary_material_v2
BS4 Not assessed Not assessed: no affected noncarrier is documented, so the VCEP's 0.5-point minimum for BS4 Supporting cannot be evaluated.
vcep_apc_specifications_supplementary_material_v2 vcep_table_1_262 PMID:26446593 PMID:21110124
BP1 N/A Not applicable: BP1 is a missense criterion, whereas c.4348C>T is a nonsense variant at codon 1450, outside the codon 1021-1035 exception.
vcep_apc_specifications_supplementary_material_v2
BP2 Not assessed Not assessed: two reports lack documented trans phase, or at least three unknown-phase occurrences with different pathogenic APC variants, required by the VCEP.
cspec vcep_apc_specifications_supplementary_material_v2 PMID:26446593 PMID:21110124
BP3 N/A Not applicable: APC VCEP BP3 is not used, and the variant is a nonsense substitution rather than an in-frame repeat-region indel.
vcep_apc_specifications_supplementary_material_v2
BP4 N/A Not applicable: c.4348C>T is a nonsense variant, whereas APC BP4 addresses synonymous or intronic variants with multiple no-impact splice predictions.
cspec vcep_apc_specifications_supplementary_material_v2
BP5 Not assessed Not assessed: no alternate pathogenic adenomatous-polyposis gene variant is documented for the required colorectal polyposis phenotype.
vcep_apc_specifications_supplementary_material_v2
BP6 N/A Not applicable: the APC VCEP does not use BP6 for unsupported benign expert opinions.
vcep_apc_specifications_supplementary_material_v2
BP7 N/A Not applicable: c.4348C>T is a coding nonsense variant, not the synonymous or intronic variant required by the APC BP7 rule.
cspec vcep_apc_specifications_supplementary_material_v2
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.